B, G., G, R., CL, W., A, L., DJ, H., RK, S., . . . DS, C. (2023). Resolution of dysglycaemia after treatment of monoclonal gammopathy of endocrine significance. European journal of endocrinology, 189(6), K25. https://doi.org/10.1093/ejendo/lvad138
Chicago Style (17th ed.) CitationB, Grant, Ratnayake G, Williams CL, Long A, Halsall DJ, Semple RK, Cavenagh JD, Drake WM, and Church DS. "Resolution of Dysglycaemia After Treatment of Monoclonal Gammopathy of Endocrine Significance." European Journal of Endocrinology 189, no. 6 (2023): K25. https://doi.org/10.1093/ejendo/lvad138.
MLA (9th ed.) CitationB, Grant, et al. "Resolution of Dysglycaemia After Treatment of Monoclonal Gammopathy of Endocrine Significance." European Journal of Endocrinology, vol. 189, no. 6, 2023, p. K25, https://doi.org/10.1093/ejendo/lvad138.